Increased cyclooxygenase-2 activity contributes to intestinal barrier disruption, as its inhibition increases ZO-1 and e-cadherin expression as well as intestinal permeability in rats with cirrhosis (102). The gene discussed is TJP1; the disease is Cirrhosis.